STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM

C F Hinz1, M E Picken, I H Lepow

  • 1Department of Medicine, School of Medicine and the Institute of Pathology, Western Reserve University, Cleveland.

Insights

Complement component C'1 is essential for the cold phase of the Donath-Landsteiner reaction, while other complement components are needed for the warm phase. This study establishes a human model for investigating complement function in disease.

Area of Science:

  • Immunology
  • Complement System
  • Hemolytic Reactions

Background:

  • The Donath-Landsteiner reaction is a crucial diagnostic tool involving complement.
  • Understanding the specific roles of complement components in this reaction is vital for disease research.

Purpose of the Study:

  • To elucidate the sequential role of complement components in the Donath-Landsteiner reaction.
  • To establish a human model for studying complement's role in disease.

Main Methods:

  • Investigating the effects of inactivating specific complement components (C'1, C'2, C'3, C'4).
  • Utilizing partially purified C'1 or C'1 esterase.
  • Employing a serum inhibitor of C'1 esterase.
  • Eluting C'1 esterase activity from erythrocytes using Na(3)EDTA.

Main Results:

  • C'1 inactivation blocks the cold phase; other component inactivation does not.
  • C'1, C'4, C'2, and C'3 are sequentially required for hemolysis.
  • C'4 reacts in cold or warm phases, while C'2 and C'3 require the warm phase.
  • C'1 esterase activity is crucial and can be eluted.
  • Calcium (Ca++) and Magnesium (Mg++) ions are required for specific steps.

Conclusions:

  • C'1 esterase plays a functional role in a human disease state.
  • A human model is established for studying complement mechanism of action.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...